Program supports cell therapy innovators in the development of next-generation, life-saving drugs and therapeutics through every stage of their journey to improve patient outcomes SINGAPORE, Feb. 7, 2023 /PRNewswire/ Thermo Fisher Scientific Inc., the world leader in serving science, today announced the launch of its new Cell Therapy Collaboration Center Program in Singapore to accelerate cell therapy development across the Asia Pacific region. The center, based in Singapore, will serve as the Asia Pacific hub to provide cell and gene therapy (CGT) developers with tailored support on their path to clinical manufacturing and commercial success. Thermo Fisher Scientific's Cell Therapy Collaboration Center in Singapore "Through our Cell Therapy Collaboration Program, we are able to offer our collaborators deep scientific engagement, instrument, and workflow support to help them optimize their manufacturing process while refining our cell therapy solutions to meet real-world chal